Observational studyMedicine2025
Association of serological markers and interstitial lung disease in patients with suspected myositis.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aims to investigate the relationship between serological markers and interstitial lung disease (ILD) in suspected myositis patients with positive myositis antibodies. We collected samples from 56 patients with suspected myositis and positive myositis antibodies before treatment. Serological markers, clinical symptoms, and diagnoses were analyzed. Among the 56 patients, 33.93% developed ILD and 66.07% did not. Univariate analysis revealed that some factors were significantly different between the no ILD and ILD groups. Multiple logistic regression analysis showed that albumin (ALB), idiopathic inflammatory myopathies (IIM), and tumor markers were independent factors influencing ILD. A receiver operating characteristic curve was constructed. Spearman's correlation analysis revealed that ALB, IIM, and tumor markers were strongly correlated with ILD. In patients with suspected immune mediated myositis and positive myositis antibodies, factors including ALB, IIM, and tumor markers are related to ILD. These findings provide a clinical basis for the prediction and early diagnosis of ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.